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ABSTRACT 
 
Background and Objectives: Dengue virus infections (Dengue) have become increasingly common in Pakistan and can 
result in case fatalities if not managed appropriately. Patients with Dengue virus infection may be asymptomatic or present 
with Dengue fever (DF), Dengue with warning signs (DWS) or severe Dengue (SD). Severity in Dengue is coincident with 
an exacerbated production of lymphocyte-induced cytokines and chemokines which are associated with plasma leakage. We 
investigated the association of circulating levels of cytokines such as Interleukin (IL)-6, tumor necrosis factor (TNF)-alpha 
and CXCL-10 in Dengue patients with differing severity of disease.
Materials and Methods: Dengue infection was confirmed by testing for human IgM to the Dengue virus. Dengue patients 
(n=58) and healthy controls (n=33) were recruited. Dengue patients were grouped into those with DF (n=39), DWS (n=15) 
and SD (n=4).  Serum IL-6, TNFα and CXCL10 levels were tested by ELISA. The Mann Whitney U test was used for sta-
tistical analysis. 
Results: Circulating levels of TNFα (p≤0.001) and CXCL10 (p≤0.001) levels were increased in Dengue patients as com-
pared with controls. When patients were stratified for disease severity, it was observed that CXCL10 was increased in DWS 
as compared to DF (p=0.046).  IL-6 levels were increased in patients with SD as compared to those with DWS (p=0.044). 
TNFα levels were not found to differ between different groups of Dengue patients. 
Conclusion: Raised CXCL10 and TNFα levels were associated with increased clinical severity of Dengue infec-
tion and probably increased disease progression due to excessive inflammation and increased vascular changes in the 
patients. 
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INTRODUCTION
Dengue infection caused by the Dengue virus 
(DENV) of the Flaviviridae family (1) is a mosqui-
to-borne disease which poses a significant global 
burden, infecting between 50-100 million people 
per year (2). The virus is rampant in tropical and 
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sub-tropical regions, where the climate favors the 
rapid growth of the mosquito vector. A variety of fac-
tors including overpopulation, poor socio-economic 
conditions, lack of public health awareness and ex-
cessive flooding have led to the rapid spread of the 
disease (3). Dengue is now a serious public health 
concern in Pakistan and 21,597 positive cases were 
reported in 2015 (4). 
Dengue infections have different manifestations 
which are classified as per WHO criteria into mild 
asymptomatic fever (DF), Dengue with warning 
signs (DWS) and severe Dengue (SD) (5). DF is de-
fined as an acute fever with at least two of the fol-
lowing symptoms: nausea, vomiting, rash, aches 
and pains, tourniquet test positive and leukopenia. 
DWS is characterized by symptoms such as abdomi-
nal pain or tenderness, persistent vomiting, mucosal 
bleeding, liver enlargement >2 cm, increase in He-
matocrit (HCT) concurrent with rapid decrease in 
platelet count. Criteria for SD is severe plasma leak-
age leading to shock and/or fluid accumulation with 
respiratory distress; severe bleeding as evaluated by 
clinician; severe organ involvement: with raised liver 
enzymes Aspartate aminotransferase (AST) or Ala-
nine aminotransferase (ALT) ≥ 1,000, together with 
central nervous system (CNS) impairment (5). 
Dengue primarily targets mononuclear cells with-
in the leucocyte system. Cells infected with the Den-
gue virus produce nitric acid and protective pro-in-
flammatory cytokines such as Interferon-gamma 
(IFN-γ), Tumour Necrosis factor-alpha (TNF-α), 
interleukin-6 (IL-6) and IL-10 to attract and acti-
vate leucocytes at the site of infection (6). TNF-α is 
a pro-inflammatory cytokine produced by T cells, 
monocytes and endothelial cells to mediates a type-
1 T cell response (7). IL-6 is a pro-inflammatory, 
pleiotropic cytokine that up-regulates  inflammatory 
responses in macrophages and  induces B cell matu-
ration (8). IL-6 is also a pyrogen and induces fever in 
patients with dengue. CXCL-10 is an IFN-inducible 
chemokine, a chemo-attractant that plays a role in the 
innate immune response. CXCL10 binds CXCR3, a 
receptor expressed on lymphocytes, and in Dengue 
infections, CXCL10 recruits activated T and NK 
cells to the site of infection (9).
The relationship between cytokine activation in 
the host in response to the pathogen in Dengue infec-
tion is complex and makes it difficult to gauge sever-
ity of disease. Previous reports have identified a role 
of IL-6, TNF-α and CXCL10 in the progression of 
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disease in Dengue infections, however, data showing 
the association of these cytokines with SD is limit-
ed. We investigated the association of the cytokines 
TNFα, IL-6 and CXCL10 in patients with differing 
Dengue disease severity as compared with healthy 
controls. This would allow us to identify markers of 
increased disease progression in Dengue infections.
 
MATeRIALS AND MeTHODS
 Subject selection. This was a hospital based case 
control study. Dengue virus positive patients diag-
nosed at the Aga Khan University Hospital (AKUH) 
Clinical Laboratory, Karachi were included in the 
study. This cohort has been described previously 
with ethical approval from the Ethical Review Com-
mittee of the Aga Khan University, Pakistan (10). 
Here we focused on cases from a subset of Dengue 
patients (n=58) from a previous study (10) who were 
in-patients at the AKUH. Retrospective review of 
patient hospital and laboratory records was conduct-
ed. Patients with Dengue infection were categorized 
into Dengue fever (DF), Dengue with warning signs 
(DWS) and severe Dengue (SD) according to the 
2009 WHO guidelines (5). For comparison, healthy 
controls (n=33) were also included in the study.
Dengue IgM eLISA. Serum samples were tested 
using Panbio Dengue IgM Capture ELISA kit as per 
manufacturer’s instruction (Panbio, Australia).
CXCL10, TNF-α and IL-6 measurement. Se-
rum samples were used to measure CXCL10, TNF-α, 
and IL-6 levels. ELISA reagents and monoclonal 
antibodies for CXCL10 were obtained from R&D 
Systems (Abingdon, UK), for TNF-α were obtained 
from Thermoscientific (USA) and for IL-6 were ob-
tained from Endogen (Rockford, IL, USA). All mea-
surements were carried out according to the manu-
facturer’s recommendations. Recombinant human 
cytokine was used to obtain a dose response curve 
with a range of detection from 6.25–500 pg/ml for 
CXCL10, 4.4-1000 pg/ml for TNFα and 6.25-1000 
pg/ml for IL-6. Readings for all cytokines were tak-
en at 450 nm and were read off a standard curve.
Statistical analysis. Data are depicted as median 
values for each group with the IQR (inter quartile 
range 25th-75th percentile) indicated in each case. 
http://ijm.tums.ac.ir
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Comparison of non-parametric data between two 
groups was performed using the Mann–Whitney 
U-test. Analysis was performed and data plotted us-
ing GRAPHPAD PRISM Version 5 (GraphPad Soft-
ware, San Diego, CA, USA).
 
ReSULTS
     Characteristics of the study group. A total of 58 
patients with Dengue infection were included in this 
study and they comprised fifteen cases of DF, thirty 
nine cases of DWS and four cases of SD. For com-
parison, 33 healthy controls who were age and sex 
matched were also included in the study. The char-
acteristics of the study population are summarized 
in Table 1. Platelet count of study subjects with DF 
(p<0.001), DWS (p<0.001) and SD (p=0.0016) were 
significantly decreased as compared with healthy 
SD 
(n= 4)
37 ± 27.3
3 (75)
1 (25)
35.3 ± 14.1*
DWS
(n= 39) 
39.9 ± 24.4
30 (77)
9 (23)
69.9 ± 15.9*
DF
(n= 15)
24.3 ± 16
9 (60)
6 (40)
156.2 ± 15.8*
HC
33±11
M: 8 (53)
 F: 7 (47)
279 ±16.2
Characteristic
Age, mean ± SD, years
Sex, Male (%)
Female (%)
Platelet count, mean ± SD error, platelets/mm3
Table 1. Characteristics of Dengue patients and healthy controls
HC, healthy controls (n=33); Cases with DF, Dengue fever (n=15); DWS, Dengue with warning signs (n=39); SD, Severe 
Dengue (n=4). Significant differences (p≤0.05) were calculated between the groups using Mann Whitney U test.
controls (Table 1).
    Increased CXCL10 and TNFα levels in patients 
with Dengue as compared with healthy controls. 
Patients with Dengue had raised levels of CXCL10 
(P <0.001) and TNFα (P <0.001) as compared with 
healthy controls (Fig. 1). However, IL-6 levels were 
found to be comparable between Dengue patients as 
compared with controls. To further investigate differ-
ential secretion of cytokines as per severity of clinical 
Dengue infections, we compared responses between 
patients across the clinical spectrum of dengue.
    Increased CXCL10 and TNFα are associated 
with increased disease severity in Dengue pa-
tients. We determined CXCL10, IL-6 and TNFα lev-
els in Dengue patients categorized into DF, DWS and 
SD. This data was also compared with the healthy 
control group (HC). CXCL10 secretion levels were 
Fig. 1. CXCL10, TNFα and IL-6 levels in patients with Dengue and healthy controls. Serum was collected from healthy con-
trols (HC, 33) and Dengue patients (n=58) and subjected to ELISA to measure CXCL10, TNFα and IL6. Graphs show median 
values with standard deviation as y error bars. Data is shown for healthy controls and patients with Dengue for a) CXCL10, b) 
TNFα and c) IL-6 secretion levels. Level of significance was defined as P ≤ 0.05. Mann Whitney U test was used to compare 
the difference between the two groups.
http://ijm.tums.ac.ir
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increased in each of the Dengue groups; DF (P 
<0.001), DWS (P <0.001) and SD (P <0.001) as com-
pared with healthy controls. When comparison was 
made between Dengue groups, CXCL10 levels were 
also found to be raised in DWS as compared with 
DF (P=0.046) (Fig. 2A).  TNFα secretion levels were 
increased in serum of individual Dengue groups; DF 
(P <0.001), DWS (P=0.005) and SD (P=0.004) as 
compared with healthy controls (Fig. 2B). There was 
no difference in circulating levels of TNFα between 
patients with DF, DWS or SD.  When serum IL-6 lev-
els were compared between HC and different Den-
gue groups, it was found that IL-6 levels were similar 
(Fig. 2C). However, within Dengue disease severity 
groups, IL-6 levels were decreased in DWS as com-
pared with DF (P=0.026) as well as SD (p=0.049).
DISCUSSION
   While up-regulation of immune responses, espe-
cially cytokine activation, is essential to control vi-
ral replication, an excess of cytokines results in in-
creased inflammation and disease progression. Pre-
vious reports have shown that there is an increased 
profile of pro-inflammatory cytokines in patients 
with Dengue fever and Dengue hemorrhagic fever 
or Dengue with warning signs have been reported, 
however, data for severe Dengue is scanty. We ob-
served that TNFα and CXCL10 levels were raised 
in patients with Dengue as compared with healthy 
controls. We observed varying circulating cytokine 
Fig. 2. CXCL10, TNFα and IL-6 levels in patients with Dengue patients with increasing disease severity and healthy endemic 
controls. Serum was collected from healthy controls (HC, 33) and Dengue patients categorized into Dengue fever (DF, n=15), 
Dengue with warning signs (DWS, n=39) and Severe Dengue (SD, n=4) and subject to ELISA for CXCL10, TNFα and IL6. 
Graphs show medians values with standard deviation as y error bars. Data is shown for healthy controls and DF, DHF and DSS 
for a) CXCL10, b) TNFα and c) IL-6 secretion levels. Level of significance was defined as P ≤ 0.05. Mann Whitney U test was 
used to compare the difference between the two groups.
levels in Dengue patients depending on the severity 
of their disease. Particularly, we observed that circu-
lating levels of TNFα and CXCL10 differed between 
Dengue patients with severe as compared with mild 
disease.
   DENV can manipulate host mechanisms for its 
own survival and can switch protective Th1 respons-
es to anti-inflammatory Th2 responses which lead to 
a more severe hemorrhagic infection (11). Up-regu-
lated expression of anti-inflammatory cytokines such 
as IL-6 and IL-10 facilitate Dengue virus replication 
and leads to disease progression (12). 
   Complement factor dysfunctions have been re-
ported in patients with haemorrhagic manifestations 
(13). Dengue viral proteins have also been shown to 
reduce complement factor production. In addition, 
some studies have reported that in infection with 
Dengue, massive T cell activation results in the ex-
acerbated production of cytokines resulting in in-
stability in vascular endothelial cell function lead-
ing to plasma leakage in advanced stages of disease 
(14). Vascular leakage is a hallmark in patients with 
severe Dengue (15). One of the leading factors at-
tributed to plasma leakage is T cell induced cytokine 
storm. Studies have shown that exacerbated cytokine 
secretion alters endothelial permeability resulting in 
severe forms of Dengue (16). 
   The Dengue virus primarily targets monocytes. 
TNFα is a monocyte derived pro-inflammatory cy-
tokine. TNFα is known to induce reactive oxygen 
and nitrogen intermediates and programs for apop-
totic cell death, increasing vascular permeability and 
http://ijm.tums.ac.ir
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ultimately leading to hemorrhage (15). Studies have 
shown that increased levels of TNFα are associat-
ed with increased vascular permeability in patients 
with Dengue. Studies have also shown that TNFα 
levels are raised in DWS (17). The role of TNFα in 
SD is still unclear. In this study, increased levels of 
TNFα observed in Dengue patients as compared with 
healthy controls are in line with above findings. 
   IL-6 is induced by TNFα and IL-1 (18). IL-6 has 
been shown to up-regulate c-reactive proteins (CRP) 
and secretory phospholipase A2 (sPLA2) and hence 
may affect endovascular permeability (18). The data 
for IL-6 levels in Dengue patients is variable. Some 
show IL-6 levels to be associated with Dengue dis-
ease severity (20). However, other studies have also 
reported lower levels of IL-6 in patients with shock 
(21). Here, we did not find any difference in IL-6 
levels between healthy controls and Dengue patients 
in general. Lack of any difference in IL-6 levels in 
the general group may be due to variation between 
groups with differing severity of Dengue. Interest-
ingly, IL-6 levels were lower in DWS as compared 
with DF where there were no warning signs. Elevated 
levels of IL-6 in SD as compared with patients with 
mild Dengue disease may indicate more pathology. 
Lower levels of IL-6 in DWS patients may reflect that 
these patients might be sampled after few days of in-
fection when IL-6 levels tend to drop followed by an 
increase until when shock occurs (21-23).
   Up-regulated levels of CXCL10 have previously 
been reported in patients infected with the Dengue 
virus (26). The increased CXCL10 in patients in-
fected with Dengue virus as compared with controls 
observed in this study is in line with the above men-
tioned findings. CXCL10 has been shown to block 
viral entry by binding to heparin sulphate which is 
a co-receptor required for Dengue virus to enter the 
host cell (9). In this study, CXCL10 levels were found 
to be higher in DWS as compared with DF. Our ob-
servation that CXCL10 levels in SD were  compara-
ble with DWS or DF groups could be due to a limited 
sample size in the SD group. 
    This study had certain limitations. Samples were 
taken from patients at a single time point whereas the 
cytokine levels are reported to be dynamic and may 
differ at different days of illness. Also, it is ideal to 
sample a patient immediately after onset of the dis-
ease, but most patients seek medical advice after few 
days of illness. Another limitation in our study was 
the low sample size of patients recruited in the study 
which may not shed enough light on the pathogenesis 
of the disease.
   Management of Dengue infections is primarily 
through supportive care. Our results show varia-
tion between IL-6 levels and increase in TNFα and 
CXCL10 serum levels to be associated with Dengue 
severity. Hence, these cytokines can be used as pre-
dictive markers of disease severity. This may assist 
in triaging patients as it may be difficult to assess 
the severity of disease at the time of diagnosis. Ear-
ly identification of more advanced disease together 
with more proactive management may result in fa-
vorable outcomes in severe infections.
    In conclusion, increased production of inflamma-
tory mediators ultimately lead to the development of 
vascular permeability with poor outcome. If TNFα 
and CXCL10 were used as predictive biomarkers of 
disease progression, these biomarkers may aid in ear-
ly identification of patients who are at a higher risk of 
more severe forms of Dengue. 
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